Publication | Closed Access

Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients Receiving Background Endothelin Receptor Antagonist and Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C2 Study)

HypertensionPulmonary Arterial HypertensionPulmonary CirculationCardiovascular DiseaseMedicineAntihypertensive TherapyVascular PharmacologyPharmacotherapyFreedom-c2 StudyPublic HealthPharmacologyOral TreprostinilPulmonary Vascular DiseaseAnesthesiology